Hyliion Holdings Corp. (NYSE American: HYLN) ("Hyliion"), a developer of sustainable, electricity-producing technologies, today announced the successful completion of the first phase of extensive ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Hyliion Holdings Corp. ("Hyliion"), a developer of sustainable, electricity-producing technologies, today announced the successful completion of the first phase of extensive performance testing ...